Skip to main content
Top
Published in: BMC Nephrology 1/2011

Open Access 01-12-2011 | Technical advance

Development and reproducibility of a computed tomography-based measurement of renal sinus fat

Authors: Meredith C Foster, Shih-Jen Hwang, Stacy A Porter, Joseph M Massaro, Udo Hoffmann, Caroline S Fox

Published in: BMC Nephrology | Issue 1/2011

Login to get access

Abstract

Background

Renal sinus fat may mediate obesity-related vascular disease, although this fat depot has not been assessed in a community-based sample. We sought to develop a protocol to quantify renal sinus fat accumulation using multi-detector computed tomography (MDCT).

Methods

Protocol development was performed in participants in the Framingham Offspring cohort who underwent MDCT. Volumetric renal sinus fat was measured separately within the right and left kidneys, and renal sinus fat area within a single MDCT scan slice was measured in the right kidney. Due to the high correlation of volumetric and single-slice renal sinus fat in the right kidney (Pearson correlation [r] = 0.85, p < 0.0001), we optimized a single-slice protocol to capture renal sinus fat in the right kidney alone. Pearson correlation coefficients were used to compare to assess the correlation of volumetric and single-slice renal sinus fat in the right kidney with other measures of adiposity. Inter- and intra-reader reproducibility was assessed using intra-class correlation coefficients.

Results

Single-slice measurements were obtained in 92 participants (mean age 60 years, 49% women, median renal sinus fat 0.43 cm2). Intra- and inter-reader intra-class correlation coefficients were 0.93 and 0.86, respectively. Single-slice renal sinus fat was correlated with body mass index (r = 0.35, p = 0.0006), waist circumference (r = 0.31, p = 0.003), and abdominal visceral fat (r = 0.48, p < 0.0001). Similar correlations were observed for volumetric renal sinus fat in the right kidney.

Conclusions

Measuring renal sinus fat is feasible and reproducible using MDCT scans in a community-based sample.
Appendix
Available only for authorised users
Literature
1.
go back to reference Eknoyan G, Lameire N, Barsoum R, Eckardt KU, Levin A, Levin N, et al: The burden of kidney disease: improving global outcomes. Kidney Int. 2004, 66: 1310-1314. 10.1111/j.1523-1755.2004.00894.x.CrossRefPubMed Eknoyan G, Lameire N, Barsoum R, Eckardt KU, Levin A, Levin N, et al: The burden of kidney disease: improving global outcomes. Kidney Int. 2004, 66: 1310-1314. 10.1111/j.1523-1755.2004.00894.x.CrossRefPubMed
2.
go back to reference Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, et al: Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007, 72: 247-259. 10.1038/sj.ki.5002343.CrossRefPubMed Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, et al: Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007, 72: 247-259. 10.1038/sj.ki.5002343.CrossRefPubMed
3.
go back to reference Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al: Prevalence of chronic kidney disease in the United States. JAMA. 2007, 298: 2038-2047. 10.1001/jama.298.17.2038.CrossRefPubMed Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al: Prevalence of chronic kidney disease in the United States. JAMA. 2007, 298: 2038-2047. 10.1001/jama.298.17.2038.CrossRefPubMed
4.
go back to reference Zoccali C, Kramer A, Jager KJ: Chronic kidney disease and end-stage renal disease: a review produced to contribute to the report 'the status of health in the European Union: towards a healthier Europe. NDT Plus. 2010, 3: 213-224. 10.1093/ndtplus/sfp127. Zoccali C, Kramer A, Jager KJ: Chronic kidney disease and end-stage renal disease: a review produced to contribute to the report 'the status of health in the European Union: towards a healthier Europe. NDT Plus. 2010, 3: 213-224. 10.1093/ndtplus/sfp127.
5.
go back to reference Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004, 351: 1296-1305. 10.1056/NEJMoa041031.CrossRefPubMed Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004, 351: 1296-1305. 10.1056/NEJMoa041031.CrossRefPubMed
6.
go back to reference Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, et al: Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004, 351: 1285-1295. 10.1056/NEJMoa041365.CrossRefPubMed Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, et al: Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004, 351: 1285-1295. 10.1056/NEJMoa041365.CrossRefPubMed
7.
go back to reference Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, et al: Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol. 2004, 15: 1307-1315. 10.1097/01.ASN.0000123691.46138.E2.CrossRefPubMed Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, et al: Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol. 2004, 15: 1307-1315. 10.1097/01.ASN.0000123691.46138.E2.CrossRefPubMed
8.
go back to reference Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D: Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int. 1999, 56: 2214-2219. 10.1046/j.1523-1755.1999.00773.x.CrossRefPubMed Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D: Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int. 1999, 56: 2214-2219. 10.1046/j.1523-1755.1999.00773.x.CrossRefPubMed
9.
go back to reference Longenecker JC, Coresh J, Powe NR, Levey AS, Fink NE, Martin A, et al: Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. J Am Soc Nephrol. 2002, 13: 1918-1927. 10.1097/01.ASN.0000019641.41496.1E.CrossRefPubMed Longenecker JC, Coresh J, Powe NR, Levey AS, Fink NE, Martin A, et al: Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. J Am Soc Nephrol. 2002, 13: 1918-1927. 10.1097/01.ASN.0000019641.41496.1E.CrossRefPubMed
10.
go back to reference Wheeler DC, Townend JN, Landray MJ: Cardiovascular risk factors in predialysis patients: baseline data from the Chronic Renal Impairment in Birmingham (CRIB) study. Kidney Int Suppl. 2003, S201-S203. Wheeler DC, Townend JN, Landray MJ: Cardiovascular risk factors in predialysis patients: baseline data from the Chronic Renal Impairment in Birmingham (CRIB) study. Kidney Int Suppl. 2003, S201-S203.
11.
go back to reference Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, et al: Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int. 2007, 71: 159-166. 10.1038/sj.ki.5002017.CrossRefPubMed Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, et al: Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int. 2007, 71: 159-166. 10.1038/sj.ki.5002017.CrossRefPubMed
12.
go back to reference Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D: Predictors of new-onset kidney disease in a community-based population. JAMA. 2004, 291: 844-850. 10.1001/jama.291.7.844.CrossRefPubMed Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D: Predictors of new-onset kidney disease in a community-based population. JAMA. 2004, 291: 844-850. 10.1001/jama.291.7.844.CrossRefPubMed
13.
go back to reference Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S: Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int. 2004, 65: 1870-1876. 10.1111/j.1523-1755.2004.00582.x.CrossRefPubMed Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S: Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int. 2004, 65: 1870-1876. 10.1111/j.1523-1755.2004.00582.x.CrossRefPubMed
14.
go back to reference Gelber RP, Kurth T, Kausz AT, Manson JE, Buring JE, Levey AS, et al: Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis. 2005, 46: 871-880. 10.1053/j.ajkd.2005.08.015.CrossRefPubMed Gelber RP, Kurth T, Kausz AT, Manson JE, Buring JE, Levey AS, et al: Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis. 2005, 46: 871-880. 10.1053/j.ajkd.2005.08.015.CrossRefPubMed
15.
go back to reference Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS: Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006, 144: 21-28.CrossRefPubMed Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS: Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006, 144: 21-28.CrossRefPubMed
16.
go back to reference Foster MC, Hwang SJ, Larson MG, Lichtman JH, Parikh NI, Vasan RS, et al: Overweight, Obesity, and the Development of Stage 3 CKD: The Framingham Heart Study. Am J Kidney Dis. 2008, 52: 39-48. 10.1053/j.ajkd.2008.03.003.CrossRefPubMedPubMedCentral Foster MC, Hwang SJ, Larson MG, Lichtman JH, Parikh NI, Vasan RS, et al: Overweight, Obesity, and the Development of Stage 3 CKD: The Framingham Heart Study. Am J Kidney Dis. 2008, 52: 39-48. 10.1053/j.ajkd.2008.03.003.CrossRefPubMedPubMedCentral
17.
go back to reference Kelly T, Yang W, Chen CS, Reynolds K, He J: Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond). 2008, 32: 1431-1437. 10.1038/ijo.2008.102.CrossRef Kelly T, Yang W, Chen CS, Reynolds K, He J: Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond). 2008, 32: 1431-1437. 10.1038/ijo.2008.102.CrossRef
18.
go back to reference Ogden CL, Yanovski SZ, Carroll MD, Flegal KM: The epidemiology of obesity. Gastroenterology. 2007, 132: 2087-2102. 10.1053/j.gastro.2007.03.052.CrossRefPubMed Ogden CL, Yanovski SZ, Carroll MD, Flegal KM: The epidemiology of obesity. Gastroenterology. 2007, 132: 2087-2102. 10.1053/j.gastro.2007.03.052.CrossRefPubMed
19.
go back to reference Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM: Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006, 295: 1549-1555. 10.1001/jama.295.13.1549.CrossRefPubMed Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM: Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006, 295: 1549-1555. 10.1001/jama.295.13.1549.CrossRefPubMed
20.
go back to reference Fry J, Finley W: The prevalence and costs of obesity in the EU. Proc Nutr Soc. 2005, 64: 359-362. 10.1079/PNS2005443.CrossRefPubMed Fry J, Finley W: The prevalence and costs of obesity in the EU. Proc Nutr Soc. 2005, 64: 359-362. 10.1079/PNS2005443.CrossRefPubMed
21.
go back to reference Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, et al: The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med. 2004, 140: 167-174.CrossRefPubMed Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, et al: The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med. 2004, 140: 167-174.CrossRefPubMed
22.
go back to reference Kurella M, Lo JC, Chertow GM: Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol. 2005, 16: 2134-2140. 10.1681/ASN.2005010106.CrossRefPubMed Kurella M, Lo JC, Chertow GM: Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol. 2005, 16: 2134-2140. 10.1681/ASN.2005010106.CrossRefPubMed
23.
go back to reference Lee JE, Choi SY, Huh W, Kim YG, Kim DJ, Oh HY: Metabolic syndrome, C-reactive protein, and chronic kidney disease in nondiabetic, nonhypertensive adults. Am J Hypertens. 2007, 20: 1189-1194.PubMed Lee JE, Choi SY, Huh W, Kim YG, Kim DJ, Oh HY: Metabolic syndrome, C-reactive protein, and chronic kidney disease in nondiabetic, nonhypertensive adults. Am J Hypertens. 2007, 20: 1189-1194.PubMed
24.
go back to reference Elsayed EF, Sarnak MJ, Tighiouart H, Griffith JL, Kurth T, Salem DN, et al: Waist-to-Hip Ratio, Body Mass Index, and Subsequent Kidney Disease and Death. Am J Kidney Dis. 2008 Elsayed EF, Sarnak MJ, Tighiouart H, Griffith JL, Kurth T, Salem DN, et al: Waist-to-Hip Ratio, Body Mass Index, and Subsequent Kidney Disease and Death. Am J Kidney Dis. 2008
25.
go back to reference Montani JP, Carroll JF, Dwyer TM, Antic V, Yang Z, Dulloo AG: Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases. Int J Obes Relat Metab Disord. 2004, 28 (Suppl 4): S58-S65.CrossRefPubMed Montani JP, Carroll JF, Dwyer TM, Antic V, Yang Z, Dulloo AG: Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases. Int J Obes Relat Metab Disord. 2004, 28 (Suppl 4): S58-S65.CrossRefPubMed
26.
go back to reference Dietrich RB, Kangarloo H: Kidneys in infants and children: evaluation with MR. Radiology. 1986, 159: 215-221.CrossRefPubMed Dietrich RB, Kangarloo H: Kidneys in infants and children: evaluation with MR. Radiology. 1986, 159: 215-221.CrossRefPubMed
27.
go back to reference Hricak H, Crooks L, Sheldon P, Kaufman L: Nuclear magnetic resonance imaging of the kidney. Radiology. 1983, 146: 425-432.CrossRefPubMed Hricak H, Crooks L, Sheldon P, Kaufman L: Nuclear magnetic resonance imaging of the kidney. Radiology. 1983, 146: 425-432.CrossRefPubMed
28.
go back to reference Chughtai HL, Morgan TM, Rocco M, Stacey B, Brinkley TE, Ding J, et al: Renal sinus fat and poor blood pressure control in middle-aged and elderly individuals at risk for cardiovascular events. Hypertension. 2010, 56: 901-906. 10.1161/HYPERTENSIONAHA.110.157370.CrossRefPubMedPubMedCentral Chughtai HL, Morgan TM, Rocco M, Stacey B, Brinkley TE, Ding J, et al: Renal sinus fat and poor blood pressure control in middle-aged and elderly individuals at risk for cardiovascular events. Hypertension. 2010, 56: 901-906. 10.1161/HYPERTENSIONAHA.110.157370.CrossRefPubMedPubMedCentral
29.
go back to reference Dwyer TM, Mizelle HL, Cockrell K, Buhner P: Renal sinus lipomatosis and body composition in hypertensive, obese rabbits. Int J Obes Relat Metab Disord. 1995, 19: 869-874.PubMed Dwyer TM, Mizelle HL, Cockrell K, Buhner P: Renal sinus lipomatosis and body composition in hypertensive, obese rabbits. Int J Obes Relat Metab Disord. 1995, 19: 869-874.PubMed
30.
go back to reference Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, et al: Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007, 116: 39-48. 10.1161/CIRCULATIONAHA.106.675355.CrossRefPubMed Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, et al: Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007, 116: 39-48. 10.1161/CIRCULATIONAHA.106.675355.CrossRefPubMed
31.
go back to reference Maurovich-Horvat P, Massaro J, Fox CS, Moselewski F, O'Donnell CJ, Hoffmann U: Comparison of anthropometric, area- and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomography. Int J Obes (Lond). 2007, 31: 500-506. 10.1038/sj.ijo.0803454.CrossRef Maurovich-Horvat P, Massaro J, Fox CS, Moselewski F, O'Donnell CJ, Hoffmann U: Comparison of anthropometric, area- and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomography. Int J Obes (Lond). 2007, 31: 500-506. 10.1038/sj.ijo.0803454.CrossRef
32.
go back to reference Rha SE, Byun JY, Jung SE, Oh SN, Choi YJ, Lee A, et al: The renal sinus: pathologic spectrum and multimodality imaging approach. Radiographics. 2004, 24 (Suppl 1): S117-S131.CrossRefPubMed Rha SE, Byun JY, Jung SE, Oh SN, Choi YJ, Lee A, et al: The renal sinus: pathologic spectrum and multimodality imaging approach. Radiographics. 2004, 24 (Suppl 1): S117-S131.CrossRefPubMed
33.
go back to reference Nikolaidis P, Gabriel H, Khong K, Brusco M, Hammond N, Yagmai V, et al: Computed tomography and magnetic resonance imaging features of lesions of the renal medulla and sinus. Curr Probl Diagn Radiol. 2008, 37: 262-278. 10.1067/j.cpradiol.2007.09.002.CrossRefPubMed Nikolaidis P, Gabriel H, Khong K, Brusco M, Hammond N, Yagmai V, et al: Computed tomography and magnetic resonance imaging features of lesions of the renal medulla and sinus. Curr Probl Diagn Radiol. 2008, 37: 262-278. 10.1067/j.cpradiol.2007.09.002.CrossRefPubMed
34.
35.
go back to reference Lee HS, Lee JS, Koh HI, Ko KW: Intraglomerular lipid deposition in routine biopsies. Clin Nephrol. 1991, 36: 67-75.PubMed Lee HS, Lee JS, Koh HI, Ko KW: Intraglomerular lipid deposition in routine biopsies. Clin Nephrol. 1991, 36: 67-75.PubMed
36.
go back to reference Jiang T, Wang Z, Proctor G, Moskowitz S, Liebman SE, Rogers T, et al: Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway. J Biol Chem. 2005, 280: 32317-32325. 10.1074/jbc.M500801200.CrossRefPubMed Jiang T, Wang Z, Proctor G, Moskowitz S, Liebman SE, Rogers T, et al: Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway. J Biol Chem. 2005, 280: 32317-32325. 10.1074/jbc.M500801200.CrossRefPubMed
37.
go back to reference Wang Z, Jiang T, Li J, Proctor G, McManaman JL, Lucia S, et al: Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes. Diabetes. 2005, 54: 2328-2335. 10.2337/diabetes.54.8.2328.CrossRefPubMed Wang Z, Jiang T, Li J, Proctor G, McManaman JL, Lucia S, et al: Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes. Diabetes. 2005, 54: 2328-2335. 10.2337/diabetes.54.8.2328.CrossRefPubMed
38.
go back to reference Bobulescu IA, Dubree M, Zhang J, McLeroy P, Moe OW: Effect of renal lipid accumulation on proximal tubule Na+/H+ exchange and ammonium secretion. Am J Physiol Renal Physiol. 2008, 294: F1315-F1322. 10.1152/ajprenal.00550.2007.CrossRefPubMedPubMedCentral Bobulescu IA, Dubree M, Zhang J, McLeroy P, Moe OW: Effect of renal lipid accumulation on proximal tubule Na+/H+ exchange and ammonium secretion. Am J Physiol Renal Physiol. 2008, 294: F1315-F1322. 10.1152/ajprenal.00550.2007.CrossRefPubMedPubMedCentral
39.
go back to reference Deji N, Kume S, Araki S, Soumura M, Sugimoto T, Isshiki K, et al: Structural and functional changes in the kidneys of high-fat diet-induced obese mice. Am J Physiol Renal Physiol. 2009, 296: F118-F126.CrossRefPubMed Deji N, Kume S, Araki S, Soumura M, Sugimoto T, Isshiki K, et al: Structural and functional changes in the kidneys of high-fat diet-induced obese mice. Am J Physiol Renal Physiol. 2009, 296: F118-F126.CrossRefPubMed
40.
go back to reference do Carmo JM, Tallam LS, Roberts JV, Brandon EL, Biglane J, da Silva AA, et al: Impact of obesity on renal structure and function in the presence and absence of hypertension: evidence from melanocortin-4 receptor-deficient mice. Am J Physiol Regul Integr Comp Physiol. 2009, 297: R803-R812. 10.1152/ajpregu.00187.2009.CrossRefPubMedPubMedCentral do Carmo JM, Tallam LS, Roberts JV, Brandon EL, Biglane J, da Silva AA, et al: Impact of obesity on renal structure and function in the presence and absence of hypertension: evidence from melanocortin-4 receptor-deficient mice. Am J Physiol Regul Integr Comp Physiol. 2009, 297: R803-R812. 10.1152/ajpregu.00187.2009.CrossRefPubMedPubMedCentral
41.
go back to reference Hall JE, Brands MW, Henegar JR, Shek EW: Abnormal kidney function as a cause and a consequence of obesity hypertension. Clin Exp Pharmacol Physiol. 1998, 25: 58-64. 10.1111/j.1440-1681.1998.tb02146.x.CrossRefPubMed Hall JE, Brands MW, Henegar JR, Shek EW: Abnormal kidney function as a cause and a consequence of obesity hypertension. Clin Exp Pharmacol Physiol. 1998, 25: 58-64. 10.1111/j.1440-1681.1998.tb02146.x.CrossRefPubMed
42.
go back to reference Reisin E, Jack AV: Obesity and hypertension: mechanisms, cardio-renal consequences, and therapeutic approaches. Med Clin North Am. 2009, 93: 733-751. 10.1016/j.mcna.2009.02.010.CrossRefPubMed Reisin E, Jack AV: Obesity and hypertension: mechanisms, cardio-renal consequences, and therapeutic approaches. Med Clin North Am. 2009, 93: 733-751. 10.1016/j.mcna.2009.02.010.CrossRefPubMed
43.
go back to reference Sijens PE, Edens MA, Bakker SJ, Stolk RP: MRI-determined fat content of human liver, pancreas and kidney. World J Gastroenterol. 2010, 16: 1993-1998. 10.3748/wjg.v16.i16.1993.CrossRefPubMedPubMedCentral Sijens PE, Edens MA, Bakker SJ, Stolk RP: MRI-determined fat content of human liver, pancreas and kidney. World J Gastroenterol. 2010, 16: 1993-1998. 10.3748/wjg.v16.i16.1993.CrossRefPubMedPubMedCentral
Metadata
Title
Development and reproducibility of a computed tomography-based measurement of renal sinus fat
Authors
Meredith C Foster
Shih-Jen Hwang
Stacy A Porter
Joseph M Massaro
Udo Hoffmann
Caroline S Fox
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2011
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-12-52

Other articles of this Issue 1/2011

BMC Nephrology 1/2011 Go to the issue